BCL2 and Huntington disease: Intriguingly, upregulation of anti-apoptotic BCL2 has been detected in Alzheimer’s and Huntington’s diseases patients, as well as in models of brain hypoxia and ischemia (Satou et al. 1995; Karlnoski et al. 2007; Sassone et al. 2013; Wnuk et al. 2020, 2021a, Wnuk, Przepiórska et al. 2021; Przepiórska et al. 2023; Pietrzak et al. 2023).